Science Explorer Interactive view Map
Company · Mississauga · Canada

Novartis (Canada)

novartis.ca/en/index.shtmlROR OpenAlex
World rank, all time
#36,083
of 42,892
Rank in Canada
#785
of 896
Research works
134
▼ 42% vs 2013–17
Citations
1.7k
12.4 per fractional work
Top-10% rate
17.4%
record average 16.5%
Open access
36%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.61× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 5.42× its world share, 1 worksImmunology and Micro…Neuroscience: 0.34× its world share, 0 worksNeuroscienceComputer Science: 0.08× its world share, 0 worksComputer ScienceHealth Professions: 0.31× its world share, 0 worksHealth ProfessionsMedicine: 3.43× its world share, 9 worksMedicineDecision Sciences: 0.36× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 7.01× its world share, 2 worksEconomics, Econometr…Psychology: 0.54× its world share, 0 worksPsychologySocial Sciences: 0.08× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 7.0×. Every wedge is a field page.

Who are the top researchers at Novartis (Canada)?

Ranked on the composite score, M Barbeau and Julie Blouin lead among researchers whose main affiliation is Novartis (Canada).

  1. 1 M Barbeau Canada · #770,884 worldwide 30 citations · 27 works
  2. 2 Julie Blouin Canada · #1,408,023 worldwide 1 citations · 59 works
All ranked researchers at Novartis (Canada)

Which keywords describe research at Novartis (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Treatment, Quality of Life, Inflammation, Economic Evaluation, Diagnosis, Cost-effectiveness Analysis and Health Utility Measures.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology17▲ 3.1×45 topics
  2. Inflammation12▲ 3.8×26 topics
  3. Treatment11▲ 6.4×25 topics
  4. Quality of Life11▲ 6.1×10 topics
  5. Diagnosis9▲ 6.5×19 topics
  6. Economic Evaluation9▲ 50×2 topics
  7. Cardiovascular Disease8▲ 5.2×14 topics
  8. Cost-effectiveness Analysis7▲ 68×1 topic
  9. Health Utility Measures7▲ 68×1 topic
  10. Heart Failure6▲ 11×8 topics
  11. Breast Cancer6▲ 16×8 topics
  12. Diabetic Retinopathy6▲ 50×2 topics
  13. Macular Degeneration6▲ 34×2 topics
  14. Clinical Trials6▲ 6.7×10 topics
  15. Metastatic Breast Cancer5▲ 56×2 topics
  16. Clinical Practice Guidelines5▲ 6.5×6 topics
  17. Guidelines5▲ 7.4×9 topics
  18. Cardiovascular Risk4▲ 9.3×4 topics
  19. Autoantibodies4▲ 13×5 topics
  20. Renal Function4▲ 25×2 topics
  21. B-Type Natriuretic Peptide4▲ 64×1 topic
  22. Global Burden4▲ 5.3×7 topics
  23. Hospital Readmission4▲ 64×1 topic
  24. Vascular Endothelial Growth Factor4▲ 28×2 topics
  25. Choroidal Thickness4▲ 53×1 topic
  26. Retinal Pigment Epithelium4▲ 53×1 topic
  27. Inflammatory Cytokines4▲ 36×3 topics
  28. Prognostic Factors4▲ 5.7×7 topics
  29. Regulatory T Cells4▲ 23×2 topics
  30. Cardiovascular Disease Prevention3▲ 32×2 topics
  31. TGF-ß3▲ 14×3 topics
  32. Hypertension3▲ 6.7×7 topics
  33. Immune System3▲ 7.3×2 topics
  34. Pharmaceutical Industry3▲ 60×2 topics
  35. Drug Development Costs3▲ 90×1 topic
  36. Generic Drugs3▲ 90×1 topic
  37. IL-173▲ 92×1 topic
  38. TH17 Cells3▲ 92×1 topic
  39. CDK4/6 Inhibitors3▲ 140×1 topic
  40. Palbociclib3▲ 140×1 topic

Which research topics does Novartis (Canada) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Advanced Breast Cancer Therapies, Lipoproteins and Cardiovascular Health and CAR-T cell therapy research.

Health Systems, Economic…2Health Systems, Economic Evaluations, Quality of Life: 2 fractional worksAdvanced Breast Cancer Therapies: 1 fractional worksLipoproteins and Cardiovascular Health: 1 fractional worksCAR-T cell therapy research: 0 fractional worksPsoriasis: Treatment and Pathogenesis: 0 fractional worksLung Cancer Treatments and Mutations: 0 fractional worksDiabetes, Cardiovascular Risks, and Lipoproteins: 0 fractional worksSystemic Sclerosis and Related Diseases: 0 fractional worksBreast Cancer Treatment Studies: 0 fractional worksSpondyloarthritis Studies and Treatments: 0 fractional works
Economics and EconometricsPulmonary and Respiratory MedicineSurgeryOncology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  2. 2 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  3. 3 Lipoproteins and Cardiovascular Health Surgery 1 works
  4. 4 CAR-T cell therapy research Oncology 0 works
  5. 5 Psoriasis: Treatment and Pathogenesis Immunology 0 works
  6. 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  7. 7 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
  8. 8 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 0 works
  9. 9 Breast Cancer Treatment Studies Cancer Research 0 works
  10. 10 Spondyloarthritis Studies and Treatments Rheumatology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.2%not open63.8%

World: 28% of research is openly available.

with international co-authors40.0%domestic only60.0%

World: 19% is written across borders.

How has Novartis (Canada)'s research output changed?

Output in 2018–2022 was 42% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Mississauga

All research institutions in Mississauga

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.